[Use of new sympatholytics in hearing disorders originating from the inner ear].
D002317:Cardiovascular Agents; D007758:Ear, Inner; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D006311:Hearing Disorders; D006801:Humans; D007759:Labyrinth Diseases; D013565:Sympatholytics
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D013565:Sympatholytics
ERGOT ALKALOIDS/therapeutic use; LABYRINTH/diseases
Anwendung neuerer Sympathicolytica bei Innenohrschwerhörigheit.